European Companies Search Engine
EU funding (€173,847): 101062042 - Mrdaml - Deciphering the Mechanistic Basis of Minimal Residual Disease and Treatment Resistance in Acute Myeloid Leukemia Fts1 Sept 2023 Financial Transparency System
Overview
Text
Project
| Subject of Grant or Contract | 101062042 - MRDAML - DECIPHERING THE MECHANISTIC BASIS OF MINIMAL RESIDUAL DISEASE AND TREATMENT RESISTANCE IN ACUTE MYELOID LEUKEMIA |
| Responsible Department | REA - European Research Executive Agency |
| Programme Name | 1.0.11 - Horizon Europe |
| Type of Contract* | Action Grant |
| Reference of the Legal Commitment (LC) | JAG.1045849 |
| Management Type | Direct management |
| Geographical Zone | - |
| Budget | BGUE |
| Action Location | - |
| Commitment Total Amount (EUR) (A+B) | 173,847.00 |
| Project end Date | 31/08/2025 |
| Commitment Contracted Amount (EUR) (A) | 173,847.00 |
| Benefiting Country | Germany 100% |
| Budget Line Name | Marie Skłodowska-Curie Actions |
| Funding Type | Grant |
| Additional/Reduced Amount (EUR) (B) | 0.00 |
| Year | 2022 |
| Source of (Estimated) Detailed Amount | The total amount of the commitment was attributed to a single beneficiary. |
| Reference (Budget) | JAG.1045849.1 |
| Commitment Consumed Amount (EUR) | 121,693.00 |
| Budget Line Number | 01 02 01 02 |
| Project Start Date | 01/09/2023 |
| Expense Type | Operational |
Beneficiaries
| Coordinator | No |
| Address | IM NEUENHEIMER FELD 280 |
| Beneficiary’s Contracted Amount (EUR) | 173,847.36 |
| Beneficiary’s Estimated Contracted Amount (EUR) | 173,847.36 |
| Postal Code | 69120 |
| Beneficiary Country | Germany |
| Beneficiary’s Estimated Consumed Amount (EUR) | 121,693.25 |
| VAT Number of Beneficiary | DE143293537 |
| Beneficiary Group Code | LE04 |
| Not-for-Profit Organisation (Nfpo) | No |
| Beneficiary Type | Public Bodies |
| Name of Beneficiary | DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG*GERMAN CANCER RESEARCH CENTER |
| NUTS2 | Karlsruhe |
| City | HEIDELBERG |
| Non-Governmental Organisation (NGO) | No |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, Heidelberg, Germany.
The visualizations for "DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG - EU funding (€173,847): 101062042 - Mrdaml - Deciphering the Mechanistic Basis of Minimal Residual Disease and Treatment Resistance in Acute Myeloid Leukemia"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
